Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2012 Sep 7;18(33):4491-506.
doi: 10.3748/wjg.v18.i33.4491.

Donation after cardio-circulatory death liver transplantation

Affiliations
Practice Guideline

Donation after cardio-circulatory death liver transplantation

Hieu Le Dinh et al. World J Gastroenterol. .

Abstract

The renewed interest in donation after cardio-circulatory death (DCD) started in the 1990s following the limited success of the transplant community to expand the donation after brain-death (DBD) organ supply and following the request of potential DCD families. Since then, DCD organ procurement and transplantation activities have rapidly expanded, particularly for non-vital organs, like kidneys. In liver transplantation (LT), DCD donors are a valuable organ source that helps to decrease the mortality rate on the waiting lists and to increase the availability of organs for transplantation despite a higher risk of early graft dysfunction, more frequent vascular and ischemia-type biliary lesions, higher rates of re-listing and re-transplantation and lower graft survival, which are obviously due to the inevitable warm ischemia occurring during the declaration of death and organ retrieval process. Experimental strategies intervening in both donors and recipients at different phases of the transplantation process have focused on the attenuation of ischemia-reperfusion injury and already gained encouraging results, and some of them have found their way from pre-clinical success into clinical reality. The future of DCD-LT is promising. Concerted efforts should concentrate on the identification of suitable donors (probably Maastricht category III DCD donors), better donor and recipient matching (high risk donors to low risk recipients), use of advanced organ preservation techniques (oxygenated hypothermic machine perfusion, normothermic machine perfusion, venous systemic oxygen persufflation), and pharmacological modulation (probably a multi-factorial biologic modulation strategy) so that DCD liver allografts could be safely utilized and attain equivalent results as DBD-LT.

Keywords: Allocation; Bile duct; Complication; Ischemia; Ischemia-reperfusion injury; Liver disease; Non-heart-beating donation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different ways of warm ischemia time definition in the controlled donation after cardio-circulatory death setting (see text for more details). True warm ischemia time (WIT) is also called complete or functional WIT; Total WIT is also called overall WIT; Agonal phase is also called withdrawal phase. BP: Blood pressure; t: Time.

Similar articles

Cited by

References

    1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–676. - PMC - PubMed
    1. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, Blanchard H, Martin AJ, Porter KA. Orthotopic homotransplantation of the human liver. Ann Surg. 1968;168:392–415. - PMC - PubMed
    1. Calne RY, Williams R. Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J. 1968;4:535–540. - PMC - PubMed
    1. Calne RY. Early days of liver transplantation. Am J Transplant. 2008;8:1775–1778. - PubMed
    1. Ascher HL. Liver transplantation--the first 25 years. West J Med. 1988;149:316–321. - PMC - PubMed

Publication types